Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMZ001 in Knee Osteoarthritis
NCT06693648Phase 3Completed
- Sponsor
- Amzell B.V.
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial in osteoarthritis (OA) comparing AMZ001 diclofenac gel with Placebo gel (2 arms). Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index Pain Sub-score at 2 weeks. Started Feb 2025; status: completed.
02
Drugs
diclofenac (AMZ001 formulation)
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06693648.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06693648.